"10.1371_journal.pmed.1001765","plos medicine","2014-12-09T00:00:00Z","Peter Würtz; Qin Wang; Antti J Kangas; Rebecca C Richmond; Joni Skarp; Mika Tiainen; Tuulia Tynkkynen; Pasi Soininen; Aki S Havulinna; Marika Kaakinen; Jorma S Viikari; Markku J Savolainen; Mika Kähönen; Terho Lehtimäki; Satu Männistö; Stefan Blankenberg; Tanja Zeller; Jaana Laitinen; Anneli Pouta; Pekka Mäntyselkä; Mauno Vanhala; Paul Elliott; Kirsi H Pietiläinen; Samuli Ripatti; Veikko Salomaa; Olli T Raitakari; Marjo-Riitta Järvelin; George Davey Smith; Mika Ala-Korpela","Computational Medicine, Institute of Health Sciences, University of Oulu, Oulu, Finland; Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland; NMR Metabolomics Laboratory, School of Pharmacy, University of Eastern Finland, Kuopio, Finland; MRC Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom; Department of Chronic Disease Prevention, National Institute for Health and Welfare, Helsinki, Finland; Institute of Health Sciences and Biocenter Oulu, University of Oulu, Oulu, Finland; Department of Medicine, University of Turku and Turku University Hospital, Turku, Finland; Department of Internal Medicine, Clinical Research Center and Biocenter Oulu, University of Oulu and Oulu University Hospital, Oulu, Finland; Department of Clinical Physiology, University of Tampere and Tampere University Hospital, Tampere, Finland; Department of Clinical Chemistry, Fimlab Laboratories, University of Tampere, Tampere, Finland; University Heart Center Hamburg, Hamburg, Germany; Finnish Institute of Occupational Health, Helsinki, Finland; Department of Obstetrics and Gynecology, Medical Research Center Oulu, Oulu University Hospital and University of Oulu, Oulu, Finland; Department of Children, Young People and Families, National Institute for Health and Welfare, Oulu, Finland; Primary Health Care, School of Medicine, University of Eastern Finland and Kuopio University Hospital, Kuopio, Finland; Primary Health Care, Central Finland Central Hospital, Jyväskylä, Finland; Department of Epidemiology and Biostatistics, MRC-PHE Centre for Environment and Health, Imperial College London, London, United Kingdom; Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland; Research Programs Unit Diabetes and Obesity, University of Helsinki, Helsinki, Finland; Wellcome Trust Sanger Institute, Hinxton, United Kingdom; Hjelt Institute, Department of Public Health, University of Helsinki, Helsinki, Finland; Research Centre of Applied and Preventive Cardiovascular Medicine, University of Turku, Turku, Finland; Department of Clinical Physiology and Nuclear Medicine, Turku University Hospital, Turku, Finland; Oulu University Hospital, Oulu, Finland; Computational Medicine, School of Social and Community Medicine, University of Bristol, Bristol, United Kingdom","Conceived and designed the experiments: PW QW AJK MT TT PS GDS MAK. Performed the experiments: AJK MT TT PS MAK. Analyzed the data: PW QW. Contributed reagents/materials/analysis tools: AJK RCR MT TT PS ASH MKa MJS SB TZ PE KPH SR VS OTR MRJ GDS MAK. Wrote the first draft of the manuscript: PW AJK RCR JS GDS MAK. Wrote the paper: PW QW AJK RCR JS MT TT PS ASH MKa JSV MJS MKä TL SM SB TZ JL AP PM MV PE KHP SR VS OTR MRJ GDS MAK. Agree with manuscript results and conclusions: PW QW AJK RCR JS MT TT PS ASH MKa JSV MJS MKä TL SM SB TZ JL AP PM MV PE KHP SR VS OTR MRJ GDS MAK. Enrolled patients: JSV MKä TL SM JL AP PM MV PE KHP VS OTR MRJ. All authors meet ICMJE criteria for authorship.","PW, AJK, PS, and MAK are shareholders of Brainshake Ltd, a startup company offering NMR-based metabolite profiling. SB has received research funding from Abbott, Abbott Diagnostics, Bayer, Boehringer Ingelheim, SIEMENS, and Thermo Fisher. SB has received honoraria for lectures from Abbott, Abbott Diagnostics, Astra Zeneca, Bayer, Boehringer Ingelheim, Medtronic, Pfizer, Roche, SIEMENS Diagnostics, SIEMENS, Thermo Fisher, and as member of Advisory Boards and for consulting for Boehringer Ingelheim, Bayer, Novartis, Roche, and Thermo Fisher. GDS is a member of the Editorial Board of PLOS Medicine. All other authors declare that no competing interests exist.","2014","12","Peter Würtz","PW",29,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA
